Oncology January 2012
Pharmacogenomic Biomarkers for Toxicities Associated With Chemotherapy
The integration of biomarkers in chemotherapy offers clinicians the ability to better manage drug toxicities.
Triple-Negative Breast Cancer
In triple-negative breast cancer, the tumor does not express
estrogen receptors, progesterone receptors, or human
epidermal growth factor receptor 2 on immunohistochemical
analysis.
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
-
• April 2026 • 2.00 Credits
Managing HIV Coinfections and Complications
-
Pain Management • March 2026 • 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
-
Cardiovascular • February 2026 • 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.